Home

Orchid Pharma Ltd Quarterly Result

Image

Orchid Pharma Ltd

NSE: ORCHPHARMA

Net Profit - Last Quarter

₹ 25.9 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Orchid Pharma Ltd for the Sep '24 is ₹ 230.22 crore as compare to the Jun '24 revenue of ₹ 251.98 crore. This represent the decline of -8.635604%.
  • The ebitda of Orchid Pharma Ltd for the Sep '24 is ₹ 37.85 crore as compare to the Jun '24 ebitda of ₹ 40.06 crore. This represent the decline of -5.5167317%.
  • The net profit of Orchid Pharma Ltd for the Sep '24 is ₹ 25.9 crore as compare to the Jun '24 net profit of ₹ 28.27 crore. This represent the decline of -8.383449%.

Results Analysis

Market Price of Orchid Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Orchid Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251603.45
14 Jan 20251647
13 Jan 20251673.65
10 Jan 20251845.95
09 Jan 20251884.75
08 Jan 20251877.2
07 Jan 20251881.1
06 Jan 20251864.7
03 Jan 20251982.8
02 Jan 20251868.35

Historical Revenue of Orchid Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Orchid Pharma Ltd

No data available

* All values are in crore

Orchid Pharma Ltd News Hub

Orchid Pharma consolidated net profit rises 212.23% in the June 2024 quarter

Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 as against

Read more

13 Aug 2024

Orchid Pharma announces board meeting date

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024. Powere

Read more

10 Aug 2024

Orchid Pharma to hold board meeting

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November 2024 Power

Read more

06 Nov 2024

Orchid Pharma consolidated net profit rises 37.58% in the September 2024 quarter

Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as aga

Read more

11 Nov 2024

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Orchid Pharma Ltd

What key financial metrics are included in Orchid Pharma Ltd's quarterly results?

Key financial metrics in Orchid Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Orchid Pharma Ltd announce its quarterly results?

Orchid Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Orchid Pharma Ltd's quarterly performance impact its stock price?

Orchid Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Orchid Pharma Ltd's quarterly results on dividends?

The impact of Orchid Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Orchid Pharma Ltd's quarterly results?

Yes, Orchid Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions